These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 3153375)
1. [Reflux esophagitis, barrett esophagus and adenocarcinoma of the esophagus]. Pera C Rev Quir Esp; 1988; 15(3):115-6. PubMed ID: 3153375 [No Abstract] [Full Text] [Related]
2. [Barrett esophagus and inflammation of gastroesophageal junction]. Voutilainen M; Färkkilä M; Sipponen P Duodecim; 2000; 116(17):1899-905. PubMed ID: 12001646 [No Abstract] [Full Text] [Related]
3. Should we screen patients for Barrett's esophagus? Yes: men with long-standing reflux symptoms should be screened with endoscopy. Strayer SM Am Fam Physician; 2011 May; 83(10):1140, 1142, 1147. PubMed ID: 21568246 [No Abstract] [Full Text] [Related]
5. Should we screen patients for Barrett's esophagus? No: the case against screening. Knox MA Am Fam Physician; 2011 May; 83(10):1148, 1150. PubMed ID: 21568247 [No Abstract] [Full Text] [Related]
6. [Strategies for monitoring patients with Barrett's esophagus--contra]. Koop H Dtsch Med Wochenschr; 2007 Aug; 132(34-35):1769. PubMed ID: 17713888 [No Abstract] [Full Text] [Related]
7. [Expression of c-myb in reflux esophagitis, Barrett esophagus and esophageal adenocarcinoma]. Ren CR; Dong L; Guo XY Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2693-5. PubMed ID: 21177182 [TBL] [Abstract][Full Text] [Related]
8. [Reflux esophagitis and Barrett's esophagus]. Yuguero del Moral L; Ojeda Giménez C; Coma del Corral MJ; Velasco Oses A; Seco Gil JL; del Moral Garcia A; Calvo Fernández S Rev Esp Enferm Apar Dig; 1982 May; 61(5):388-97. PubMed ID: 7122953 [No Abstract] [Full Text] [Related]
9. Timing of bile and acid reflux into the esophagus. Netzer P; Inauen W Am J Gastroenterol; 2002 Jan; 97(1):207. PubMed ID: 11808955 [No Abstract] [Full Text] [Related]
17. Prediction of malignant potential in reflux disease: are cytokine polymorphisms important? Gough MD; Ackroyd R; Majeed AW; Bird NC Am J Gastroenterol; 2005 May; 100(5):1012-8. PubMed ID: 15842572 [TBL] [Abstract][Full Text] [Related]
18. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297 [TBL] [Abstract][Full Text] [Related]
19. Role of obesity in Barrett's esophagus and cancer. Murray L; Romero Y Surg Oncol Clin N Am; 2009 Jul; 18(3):439-52. PubMed ID: 19500735 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]